Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ALVR | Allovir, Inc. | Chief Medical Officer | $304K | Oct 4, 2021 | ||
FMTX | Forma Therapeutics Holdings, Inc. | EVP, Research & Development | Oct 14, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|